zum Inhalt
Header Image

04: Biomedical and Pharmaceutical Engineering – Schlüsseltechnologien des 21. Jahrhunderts

-
Hauptschule
Breakout /
in englischer Sprache

Die Herausforderungen in der biomedizinischen Technik sowie in der Entwicklung und Produktion moderner Therapeutika sind drastisch gestiegen. Ein wichtiges Indiz dafür ist die signifikante Reduktion neuer Medikamentenzulassungen seit 1995.
Der Arbeitskreis befasst sich mit modernen Möglichkeiten, dieser Entwicklung entgegenzusteuern, zum Beispiel durch den Einsatz von „high-throughput“ Methoden, wie „lab-on-a-chip“, oder durch Nanotechnologie und modernes Qualitäts- und Risikomanagement, gepaart mit prädiktiven Modellierungsansätzen. Computational medicine etwa soll dazu beitragen, Alterserkrankungen wie Atherosklerose oder Osteoporose besser zu analysieren. Eine voranschreitende digitalisierte und personifizierte Betrachtung des Menschen wird zur verbesserten medizinischen Fürsorge führen.

Consultant; retired Head, Technology Liaison, Global Quality Operations, Novartis Pharma AG, Dornach
Professor of Engineering Science; Director, Auckland Bioengineering Institute, The University of Auckland
Direktor, Institut für Biomechanik, Eidgenössische Technische Hochschule Zürich
James M. and Marsha McCormick Chair of Biomedical Engineering; Samuel B. Eckert Professor of Chemical Engineering, School of Chemical and Biomolecular Engineering, Cornell University, Ithaca
Full Professor and Chair of Biomechanics, Graz University of Technology; Adjunct Full Professor and Chair of Biomechanics, Department of Solid Mechanics, School of Engineering Sciences, Royal Institute of Technology (KTH), Stockholm; Visiting Professor, Department of Mathematics, University of Glasgow, Graz Chair
Head, Institute of Process- and Particle Engineering, Graz University of Technology; Scientific Director, Research Center Pharmaceutical Engineering GmbH, Graz Chair
Ph.D. Researcher, Institute of Process and Particle Engineering, Graz University of Technology Coordination

Dr. Fritz ERNI

Consultant; retired Head, Technology Liaison, Global Quality Operations, Novartis Pharma AG, Dornach

1969 Ph.D. from the Swiss Federal Institute of Technology (Dr. sc.nat. ETH) in Zurich
 Started his career in Japan in research at Hitachi Ltd.
1974-1986 Several positions in the analytical research and development of new drug substances and products at Sandoz in Basel
1986-1995 Head of Analytical Research and Development at Sandoz in Basel
1995-2000 Several management positions in Quality Assurance/Control at Sandoz and after the merger within Novartis
2000-2002 Director of Novartis Pharmanalytica SA in Locarno, Switzerland
2002-2009 Head of Technical Liaison, Global Quality Operations of Novartis in Basel (responsible for the establishing of Novartis Global activities on Process Analytical Technologies (PAT) and Quality by Design)
 Since 2009 Consultant (retired from Novartis after 35 years in the pharmaceutical Industry)

Ph.D. Peter J. HUNTER

Professor of Engineering Science; Director, Auckland Bioengineering Institute, The University of Auckland

1971 B.E. in Engineering Science (1st Class Hons) at Auckland University, NZ
1971-1972 Master s research in the Dept. of Theoretical & Applied Mechanics at Auckland University
1973-1975 Postgraduate research for D.Phil. in Physiology at Oxford University
1975-1977 Research Fellow and tutor at St. Catherine's College, Oxford University
Research Fellow at Rutherford Laboratory, UK
1977-1978 Engineering Lecturer at Keble College, Oxford
since 1979 Lecturer to Professor in Engineering Science at Auckland University
1998-1999 Associate Dean of Research in the School of Engineering
1999-2000 James Cook Fellow of the Royal Society of New Zealand
2001 Distinguished Professor, University of Auckland
since 2001 Director of Bioengineering Institute at Auckland University
since 2003 Director, Computational Physiology, University of Oxford

Dr. Ralph MÜLLER

Direktor, Institut für Biomechanik, Eidgenössische Technische Hochschule Zürich

1994 Promotion in Elektrotechnik, Eidgenössische Technische Hochschule Zürich
 Anschließend arbeitete er als Mikrotomographie Projektmanager für die BIOMED1 Concerted Action der Europäischen Union.
1996 Wechsel an die Harvard Medical School in Boston, wo er als tenure-tracked Assistant Professor of Orthopedic Surgery und als stellvertretender Direktor des Orthopedic Biomechanics Laboratory tätig war.
2000-2006 SNF Professor für Bioingenieurwissenschaften am Institut für Biomedizinische Technik der Universität und ETH Zürich
seit 2006 Professor für Biomechanik am Departement für Maschinenbau und Verfahrenstechnik und der Direktor des Instituts für Biomechanik an der ETH Zürich

Ph.D. Michael L. SHULER

James M. and Marsha McCormick Chair of Biomedical Engineering; Samuel B. Eckert Professor of Chemical Engineering, School of Chemical and Biomolecular Engineering, Cornell University, Ithaca

1969 B.Sc., Chemical Engineering, University of Notre Dame (Notre Dame, IN)
1973 Ph.D., Chemical Engineering, University of Minnesota (Minneapolis, MN)
1974-1979 Assistant Professor of Chemical Engineering, Cornell University
1979-1983 Associate Professor of Chemical Engineering, Cornell University
1980-1981 Visiting Scholar, Department of Chemical Engineering, University of Washington, Seattle
1984-1991 Professor of Chemical Engineering, Cornell University
1985-1988 Founding Editor, Biotechnology Progress (Board since 1988)
1986-2006 Editorial Board, AIChE (American Institute of Chemical Engineers) Journal
1988-1989 Visiting Prof., Dept. of Chemical Engineering, University of Wisconsin, Madison
since 1990 Editorial Board, Biotechnology and Bioengineering
1991-2001 Board of Directors, Phyton
since 1992 Samuel B. Eckert Professor of Chemical Engineering, Cornell University
since 1993 Director, Bioengineering Program
since 1994 Editorial Board, Enzyme and Microbial Technology
1995 Guest Professor, Institute for Biotechnology, ETH Zurich, Switzerland
1996-2008 Editorial Board, Cambridge University Press
1998-2002 Director, Chemical and Biomolecular Engineering
2001-2003 Board of Directors, American Institute of Chemical Engineers
2002-2004 Director, Biomedical Engineering Program
since 2004 James and Marsha McCormick Chair of Biomedical Engineering
  Scientific Advisory Board, HuRel
2005-2008 Scientific Advisory Board, Institute of Chemical and Engineering Sciences, Singapore

Dipl.-Ing. Dr. techn. Gerhard A. HOLZAPFEL

Full Professor and Chair of Biomechanics, Graz University of Technology; Adjunct Full Professor and Chair of Biomechanics, Department of Solid Mechanics, School of Engineering Sciences, Royal Institute of Technology (KTH), Stockholm; Visiting Professor, Department of Mathematics, University of Glasgow, Graz

1985 MSc. Civil Engineering (with distinction), Graz University of Technology (TU Graz), Austria
1986-1987 National Service at Red Cross
1987-1997 Assistant and Docent at the Institute of Strength of Materials, TU Graz
1990 PhD in Mechanical Engineering (with distinction), TU Graz
1991 Visiting Scholar at University of Shenyang, P.R. China
1993-1995 Post-Doctoral Fellow at the Division of Applied Mechanics, Department of Mechanical Engineering, Stanford University; with late Prof. JC Simo
1996 Habilitation in "Mechanics" Vienna University of Technology
1998-2004 Associate Professor and Head of the Research Group "Computational Biomechanics", Institute of Structural Analysis, TU Graz
2003 Visiting Professor, Universidad Politécnica de Cataluña, Barcelona, Spain
Offer of a Chair (C4) in Continuum Mechanics, University of Kassel, Germany (not accepted)
2004-2007 Full Professor and Chair of Biomechanics, Royal Institute of Technology (KTH), Stockholm, Sweden
2007 Visiting Professor, University of Zaragoza, Spain
since 2007 Full Professor and Chair of Biomechanics, Graz University of Technology; Adjunct Full Professor and Chair of Biomechanics, Department of Solid Mechanics, School of Engineering Sciences, Royal Institute of Technology (KTH), Stockholm
since 2009 Visiting Professor, Department of Mathematics, University of Glasgow, Scotland

DI Dr. techn. Johannes KHINAST

Head, Institute of Process- and Particle Engineering, Graz University of Technology; Scientific Director, Research Center Pharmaceutical Engineering GmbH, Graz

1991 DI in Chemical Engineering (highest distinction), Graz University of Technology
1995 Ph.D. in Chemical Engineering (highest distinction), Graz University of Technology
1996-1998 Post Doc in Chemical Engineering, University of Houston, Houston (TX)
1998-2003 Assistant Professor, Rutgers University, Piscataway (NJ)
since 2003 Tenured Professor, Rutgers University, Piscataway (NJ)
2003-2006 Director of the Rutgers Catalyst Consortium, Rutgers University, Piscataway (NJ)
since 2005 Professor of Pharmaceutical and Process Engineering
2005-2008 Marie Curie Chair of the European Union
since 2006 Head of the Institute for Process Engineering, Graz University of Technology
since 2008 Scientific Director of the Research Center for Pharmaceutical Engineering GmbH

Technologiegespräche

Timetable einblenden
Genre : Alle

27.08.2009

08:00 - 10:30Technologiebrunch der Tiroler ZukunftsstiftungSocial
11:00 - 11:10Eröffnung durch das Europäische Forum AlpbachPlenary
11:10 - 12:00EröffnungsreferatePlenary
12:00 - 14:00Wege aus der Krise – neue Perspektiven durch Forschung und Innovation?Plenary
14:30 - 16:00Die Zukunft der StammzellenforschungPlenary
18:00 - 19:30Blick in die Vergangenheit – das Rätsel unserer HerkunftPlenary
19:30 - 21:30Abendempfang gesponsert durch Forschung Austria in Kooperation mit der GFF und dem BMVITSocial

28.08.2009

07:00 - 13:30Arbeitskreis 01: Können wir unseren Nahrungsmitteln vertrauen?Breakout
07:00 - 13:30Arbeitskreis 02: Forschungs-, technologie- und innovationspolitische (FTI) Strategien im internationalen VergleichBreakout
07:00 - 13:30Arbeitskreis 03: „Säen und Ernten“ in der bio(techno-)logischen Forschung: Vom atomaren Bauplan der Proteine zur Entwicklung neuer Arzneimittel und ihrer klinischen AnwendungBreakout
07:00 - 13:30Arbeitskreis 04: Biomedical and Pharmaceutical Engineering – Schlüsseltechnologien des 21. JahrhundertsBreakout
07:00 - 13:30Arbeitskreis 05: Infratech – Krise als ChanceBreakout
07:00 - 13:30Arbeitskreis 06: Kreativität – Treibstoff der Wissensgesellschaft?Breakout
07:00 - 13:30Arbeitskreis 07: Creative Industries vs. Old Economy: Wohin steuert die Wirtschaft?Breakout
07:00 - 13:30Arbeitskreis 08: Universitäten: Verantwortung für die ZukunftBreakout
07:00 - 13:30Arbeitskreis 09: Vertrauen in die Zukunft – Investieren in die ForschungBreakout
07:00 - 13:30Arbeitskreis 10: Digital Government im Spannungsfeld zwischen Bürger und VerwaltungBreakout
07:00 - 13:30Arbeitskreis 11: E-Mobility AustriaBreakout
07:00 - 16:00Junior Alpbach – Wissenschaft und Technologie für junge MenschenBreakout
07:00 - 13:00Ö1 Kinderuni Alpbach – Wissenschaft und Technologie für KinderBreakout
07:00 - 13:00Technologieworkshop: Trend-Radar Gesellschaftliche EntwicklungenBreakout
08:00 - 13:00Sonderveranstaltung: Positionierung Österreichs im internationalen WissensraumBreakout
14:30 - 15:45Kreativität. Wie Kinder lernen – Lernen wie die Kinder?Plenary
16:15 - 18:00Innovative Forschungsstandorte – Regionen im WettbewerbPlenary

29.08.2009

07:30 - 08:45Vertrauen in die Wissenschaft? Integrität in der wissenschaftlichen ForschungPlenary
08:45 - 09:30Die Zukunft des Universums – Perspektiven für Astrophysik und KosmologiePlenary
10:00 - 11:00I-Brain – die technologische Evolution des Gehirns?Plenary
11:00 - 11:15Abschluss-StatementPlenary
11:15 - 12:00Imbiss zum Abschluss der VeranstaltungSocial